Instalab
logoInstalab

Large HDL-P

See whether a high good-cholesterol result still fits a protective pattern, especially with diabetes, kidney disease, or known heart disease.
4.9 (4,286 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Large HDL-P test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
Get a baseline on how your cholesterol cleanup particles are distributed as the science on this marker matures.
Told Your HDL Is Very High
Very high HDL isn't always protective. This shows whether your large particles fit a healthy pattern or a worrying one.
Living With Diabetes or Kidney Disease
In these conditions, more large HDL particles has tracked with more heart events, which a standard panel can miss.
Going Through Menopause
HDL cholesterol often rises at menopause while large particles fall. This shows which way your particles are moving.

About Large HDL-P

If your HDL cholesterol came back high and you took that as good news, this test checks whether the good news holds up. Large HDL-P (large high-density lipoprotein particle number) estimates the biggest HDL particles in circulation using NMR. In people who already have heart disease, diabetes, or kidney disease, having more of the largest particles has repeatedly gone along with worse outcomes.

In several studies of the general population, the same particles look protective, so the number means little on its own. It becomes useful when you read it against your overall health, your total HDL particle count, and your other lipids. This is still a research-grade marker with no agreed cutoffs. Current lipid guidelines recommend against NMR particle testing beyond a standard lipid panel, ApoB, and Lp(a), because adding NMR measures to standard lipids hasn't meaningfully improved risk prediction in prospective studies. Treat it as added detail on top of those tests, with your own baseline and trend as the most valuable thing it gives you.

What the Test Counts

HDL is the family of particles that picks up extra cholesterol from tissues, including artery walls, and carries it back to the liver for disposal. Scientists call this trip reverse cholesterol transport. HDL starts out as a small, nearly empty particle built around a protein made by the liver and intestine, and it swells as it loads up with cholesterol, moving from small to medium to large.

Large particles are the mature, cholesterol-heavy end of that process, and they can deliver cholesterol to receptors on liver cells. A high count can mean cholesterol is flowing into HDL well, or that the liver isn't clearing the particles efficiently, and the count by itself can't tell those two apart. The different sizes also seem to do different jobs: small HDL is better at pulling cholesterol out of cells and calming inflammation, while large HDL appears to help keep LDL from moving into the artery wall.

This test reports the concentration of large HDL particles in micromoles per liter, measured by NMR (nuclear magnetic resonance). NMR reads the signal that particles of each size give off and estimates particle counts from that signal. That is a different quantity from the HDL cholesterol on a standard panel, which tells you how much cholesterol all your HDL particles carry combined.

Where Large Particles Look Protective

In people without established disease, more large HDL particles has mostly been a good sign. The clearest examples come from long-running community studies that tracked heart, valve, and metabolic outcomes.

Who Was StudiedWhat Was ComparedWhat They Found
6,784 adults from several ethnic groups, followed long termMore versus fewer large HDL particlesLess calcium building up in the aortic valve, and slower growth when it did appear
6,699 adults from MESA, analyzed by kidney functionLarger versus smaller HDL particlesLower cardiovascular risk, with the link strongest in people whose kidneys filtered less well
4,828 Dutch adults without diabetesLarger versus smaller average HDL sizeLower chance of developing type 2 diabetes

Sources: MESA (Bortnick et al.); MESA (Lamprea-Montealegre et al.); PREVEND Study (Sokooti et al.).

A population study of 962 Dutch adults also found that people with more large HDL particles had lower white blood cell and neutrophil counts, which fits with large HDL calming the bone marrow's production of inflammatory cells. In the community studies, the protective link was stronger when HDL lacked a protein called apolipoprotein C-III, so particle content seems to matter as well as size.

What this means for you: if you're generally healthy, with good blood sugar, normal kidney function, and a low ApoB (apolipoprotein B), more large particles can fit a cleanup system that's working normally. It doesn't offset a high ApoB, which remains the main lipid driver of plaque.

When More Large Particles Travels With More Risk

The pattern flips in people who are already sick. Across several high-risk groups, more large or very large HDL particles went along with more cardiovascular events and deaths, while small and total HDL particles kept their protective link.

Who Was StudiedWhat Was ComparedWhat They Found
People with established cardiovascular disease, pooled across studiesMore versus fewer large HDL particlesHigher death rate from any cause, while small and total HDL particles were linked to lower death rates
1,991 adults with type 2 diabetes in Hong KongVery large versus smaller HDL particlesVery large particles went with higher death rates; small particles went with fewer heart events and deaths
325 people with chronic kidney diseaseLarger HDL size and more large particles versus fewerMore new heart and blood vessel events, independent of HDL cholesterol and HDL's cholesterol-removal ability

Sources: Sharifi-Zahabi et al. (meta-analysis); Hong Kong Diabetes Biobank (Jin et al.); Mathew et al.

Studies of people with coronary artery disease point the same way. In 214 men with stable coronary disease and in 3,972 people having cardiac catheterization, total and small or medium HDL particles predicted survival better than HDL cholesterol did, while large particles offered no protection and larger average HDL size tended toward higher mortality. Across 16,925 people in several cohorts, more total HDL particles meant less heart failure, but larger average HDL size meant more.

The very top of the HDL range carries its own warning. In analyses of the IDEAL trial and EPIC-Norfolk cohort, very high HDL cholesterol and very large average HDL size were linked to more coronary disease. In 429,792 UK Biobank participants, very high HDL cholesterol went with higher mortality in people with high blood pressure, and the authors attributed much of that link to larger HDL particles.

Both sets of findings fit together once you treat this count as a sign of what kind of HDL you have rather than a good-or-bad score. When metabolism is healthy, large particles reflect a cleanup system that fills and empties normally. In diabetes, kidney disease, and chronic inflammation, large HDL can become loaded with triglycerides, lose its anti-inflammatory abilities, and linger because the liver isn't clearing it, so a high count can reflect a backlog of worn-out particles. That's why the same number can be reassuring in one person and a warning in another.

All of these links come from observational studies. Genetic studies and trials of HDL-raising drugs such as niacin and CETP inhibitors haven't shown that changing HDL particles lowers heart risk, so this count is a risk marker, not a target to treat.

Low Counts and Insulin Resistance

A low count has its own story. It often points to insulin resistance. That means your cells respond poorly to insulin. In a study of 148 adults, insulin resistance and type 2 diabetes shrank HDL particles while enlarging the triglyceride-rich particles that feed plaque. Young people with obesity and a high ratio of triglycerides to HDL cholesterol showed the same unfavorable shift across their lipoprotein subclasses.

Low counts can also run in families. In Finnish families with inherited low HDL, smaller HDL particles and fewer large ones went along with thicker carotid artery walls, an early sign of atherosclerosis. Reviews of HDL composition similarly link low levels of large and very large HDL to higher atherosclerotic risk.

What this means for you: a low count alongside high triglycerides, low HDL cholesterol, or extra weight around the middle is a reason to check how your body handles sugar, since that's usually the underlying problem.

Menopause and the HDL Shift

Menopause is where HDL cholesterol is most likely to mislead. In 471 women tracked across the menopause transition, HDL cholesterol went up, yet large HDL particles and average HDL size went down, small particles and HDL triglyceride content rose, and the cholesterol-removal capacity of each particle fell. A related analysis linked these shifts to higher levels of complement proteins C3 and C4, which are part of the body's inflammatory response.

Midlife HDL patterns also seem to matter later. In the same research program, women with more favorable HDL profiles in midlife had less carotid plaque years afterward, although body weight explained part of that link. If you're in or past menopause, a rising HDL cholesterol shouldn't be read as better protection until you know what the particles are doing.

Why a Single Reading Can Fool You

The biggest source of error here is the measurement itself. HDL particle counts from NMR don't always agree with other methods, and lipid specialists have cautioned against reading the absolute numbers too literally.

  • The counting method: NMR estimates particle counts from spectral signals. NMR, ion mobility, and gel-based methods sort HDL by size in different ways and report different units, so a result from another method can't be compared with this one. There's also no universal standardization program for NMR particle counts, and much of the outcome research used a single NMR platform, so results from different NMR labs may not line up exactly.
  • Recent serious illness: in 40 people with septic shock, HDL fell sharply and shifted toward large particles, a pattern tied to poorly functioning HDL. Test only after you've fully recovered from a significant illness or surgery.
  • Fasting status: research on fasting and HDL size is limited and inconsistent, with some studies showing small shifts in the size distribution. Test under the same conditions each time.
  • Sample handling: lipid results depend on how quickly the blood is processed and how it's stored, and occasional lab factors can affect a single reading.

Tracking Your Trend

How much large HDL-P varies from week to week in the same person hasn't been well measured. HDL cholesterol, a related and more standardized measure, still varies within a person, and a count of one particle subgroup is unlikely to be steadier than that. A single reading is a starting point, and the direction across several readings is what you can act on.

When you repeat it, use the same lab and the same method, and keep fasting status consistent. Read the large particle count together with total HDL particles and average HDL size, since a shift toward small particles with stable totals means something different from a drop in everything.

Be careful about using this number by itself to judge whether a lifestyle change is working. Aerobic exercise trials have increased large HDL-P on NMR on average, but the response is modest and varies by person. Read the change with triglycerides, ApoB, total HDL particles, and the clinical reason you tested.

What to Do With an Out-of-Pattern Result

Because this marker depends so heavily on context, the next step depends on what else your results show.

  • High count with diabetes, kidney disease, high blood pressure, or known heart disease: treat it as a possible sign of poorly cleared HDL. Check ApoB, triglycerides, HbA1c (hemoglobin A1c), hs-CRP (high-sensitivity C-reactive protein), and kidney tests such as eGFR (estimated glomerular filtration rate) and cystatin C, and consider a coronary calcium scan and an HDL function test.
  • High count with very high HDL cholesterol but otherwise healthy: confirm on a repeat test, check ApoB, and don't count the HDL as a reason to relax on LDL-lowering.
  • Low count with high triglycerides or low HDL cholesterol: look for insulin resistance with fasting insulin, glucose, and HbA1c, and track waist size.
  • Low total and small HDL particles: in many cohorts this was the stronger warning sign, so weigh it more heavily than the large-particle count.

A lipidologist or preventive cardiologist is the right specialist if your pattern is unusual, such as extremely high HDL with a family history of early heart disease, or an abnormal count that persists while ApoB is already well controlled. An endocrinologist makes sense if the workup turns up diabetes or a thyroid or hormonal problem. In every pattern, ApoB remains the number to drive down first, and this count adds detail on top of it.

What Moves This Biomarker

Evidence-backed interventions that affect your Large HDL-P level

↑ Increase
Take a CETP (cholesteryl ester transfer protein) inhibitor
These drugs push HDL cholesterol up dramatically and enlarge HDL particles, but for most drugs in the class the higher HDL did not translate into fewer heart attacks. Trials of evacetrapib and torcetrapib reported large HDL cholesterol increases, and the class shifts HDL toward larger particles. Expect this number to rise without assuming your heart risk has fallen to match.
MedicationStrong Evidence
↑ Increase
Do regular endurance (aerobic) exercise training
Regular endurance training tends to raise large HDL-P modestly by NMR and improve the broader lipoprotein pattern. A pooled analysis of 1,555 adults across 10 exercise interventions found large HDL-P increased while large VLDL and small LDL particles fell. The change is real, but small enough that you should judge the program mainly by ApoB, triglycerides, blood pressure, fitness, and glucose markers.
ExerciseModest Evidence
↑ Increase
Take a statin when ApoB or LDL risk calls for it
Statins are the standard first drug for lowering LDL cholesterol and heart risk. In JUPITER, rosuvastatin raised total HDL particle number and average HDL size modestly, and statin trials usually raise HDL cholesterol a little. Direct large-particle count changes are less certain, so if this result rises after starting a statin, the main benefit still shows up in ApoB and LDL.
MedicationModest Evidence

Frequently Asked Questions

References

45 studies
  1. Elham Sharifi-zahabi, Nooshin Nasiri, Fatemeh Hajizadeh-sharafabad, Sobhan Mohammadi, S. Shahbazi, Nahid SalehiLipids in Health and Disease2025
  2. Qiao Jin, E. Lau, a. Luk, C. Tam, R. Ozaki, Cadmon K. P. Lim, Et Al.Cardiovascular Diabetology2022
  3. A. Mathew, Yun Han, Vetalise C. Konje, Yanhong Guo, Jaeman Byun, Alexander George, Julian Meza, S. Rajagopalan, Y. E. Chen, Brenda Gillespie, R. Saran, Subramaniam PennathurPLOS One2025
  4. A. Bortnick, Petra Buzkova, James D. Otvos, Majken K. Jensen, Michael Y. Tsai, M. Budoff, Et Al.Arteriosclerosis, Thrombosis, and Vascular Biology2022

Large HDL-P Testing Option

NMR Lipoprofile

$75

See the particle-level heart and metabolic risk that a standard cholesterol test can quietly leave behind.

Includes 9 biomarkers:
Large HDL-PLDL-PSmall LDL-PLDL SizeHDL-P
FSA/HSA eligible
No Rx needed
HIPAA compliant